Mama-Match
TMates review
Compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than TMates
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
$99/mo semaglutide, $149/mo tirzepatide, one flat price with both medications in a single account — and an intake that walks you through it instead of cornering you with a quiz.
- Meet Synergy Rx
$199–299/mo semaglutide, $349–399/mo tirzepatide depending on form, plus brand options, all published on its products page with no consult required.
- Meet Strut Health
$149/mo injectable semaglutide, $99/mo oral lozenge, $325/mo tirzepatide ($199 on auto-refill) — with a February 2026 FDA warning letter you should read first.
TMates at a glance
- Semaglutide
- $249/mo
- Tirzepatide
- $297/mo
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored TMates
Each factor is judged from TMates's actual pricing, disclosures and support, then combined into the Mama-Match Score of 67/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The start feels transactional — more cash register than welcome.
Fair pricing once you get past any teaser rate or plan structure.
Little public detail about who oversees your care, and how.
Coverage is limited or gated behind a signup.
Support is thin once the prescription ships.
Canceling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Medium
- Primary source
- tmates.com
$249 and $297 is what an ordinary month costs. The better-looking figures — $158 and $167 — mean handing over $1,900 or $1,999 in a single charge. TMates publishes no state list, so whether it reaches you is something you find out after starting.
What to expect when you sign up
We walked TMates's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1The signup call to action stays on tmates.com (https://tmates.com/shop)
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $249 | Flat across every dose, injectable or oral |
| Compounded tirzepatide | $297 | Flat across every dose, injectable or oral |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what TMates disclosed publicly at our last review and change often; confirm the current number on TMates's site.
What we like
- One price per molecule across every dose, so titrating up never raises the bill
- Oral and injectable cost exactly the same, which is rare and removes a hidden penalty for choosing the pill
- Publishes the full three, six and twelve-month ladder with the real totals, not just a per-month figure
- Every advertised discount reconciles against the month-to-month rate when you check the arithmetic
The caveats
- Publishes no list of the states it serves, so availability is unknown until you start
- The longer terms are prepaid commitments, so the cheapest per-month numbers are not month-to-month prices
- No postpartum, breastfeeding or PCOS guidance published anywhere on the site
TMates for moms: our verdict
Compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting. It runs about $249/mo, flat across every dose — pricier than the category, so the extras have to earn it.
We looked at TMates the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What TMates actually costs
- Compounded semaglutide — Flat across every dose, injectable or oral: $249/mo
- Compounded tirzepatide — Flat across every dose, injectable or oral: $297/mo
For context, the typical ongoing price on our list is around $179/mo, so TMates sits at the pricier end.
TMates prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.
That price covers the consult and the medication.
The medications TMates prescribes
TMates prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. These are compounded formulas from a licensed pharmacy — the reason the price stays low — but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
There's a needle-free oral or sublingual option on the menu, which appeals to moms who have been putting off injections — just set your expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions used in the trials.
Where it operates. TMates lists its coverage as: Not published.
Where TMates fits — and where it doesn't — for moms
A good fit if…
- you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- you want friction-free cancellation — the fine print here is where the complaints cluster.
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
A standing caution for moms: GLP-1 medications are not proven safe during pregnancy or breastfeeding, and every label advises against use. None of this changes that — plan the timing with your own healthcare provider.
The bottom line
TMates is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: Someone who wants the dose ladder to stop mattering to the bill and prefers the commitment terms disclosed before checkout.
Keep comparing TMates
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
TMates, answered
- How much does TMates cost?
- As of our last review, TMates's compounded pricing starts around $249/mo ($249/mo semaglutide, $297/mo tirzepatide). Confirm the current all-in price on TMates's site before you commit.
- Is TMates safe to use while breastfeeding?
- Here is the honest answer: no GLP-1 — compounded or brand-name — is established as safe during pregnancy or breastfeeding, and the labels advise against use; TMates is no exception. Plan any GLP-1 for after weaning, and talk the timing through with your own clinician.
- Does TMates offer both semaglutide and tirzepatide?
- Yes — TMates offers both. Tirzepatide's dual action is often preferred when insulin resistance is driving the weight, which matters with PCOS and after gestational diabetes.
- Where does TMates land in your ranking?
- TMates scores 67/100 on our Mama-Match Score (rank #59), which weights six things that matter to a first-timer. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Prices, states and verification reflect what TMates disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.